Novosound Unveils Novel Ultrasound Device for Blood Pressure Monitoring

Novosound Unveils Novel Ultrasound Device for Blood Pressure Monitoring

Facebook
Twitter
LinkedIn

Novosound, a pioneering Scottish medical technology startup developing innovative medical imaging sensors, has unveiled the first-ever ultrasonic device for blood pressure monitoring.

According to the company’s announcement on Monday, the breakthrough paves the way for the development of tiny blood pressure monitoring devices that can be integrated into other wearables, such as smart rings and smartwatches, while still achieving accuracy levels comparable to conventional electronic cuff devices.

Novosound’s ultrasonic blood pressure monitor builds on the company’s Slanj platform technology developed in collaboration with the Texas Medical Centre in Houston.

The announcement of the breakthrough in developing the world’s first wearable ultrasound device for blood pressure monitoring follows the company’s recent $2.6 million investment round, which will help advance the novel device to commercialization.

Revolutionizing Cardiac Care with Innovative Ultrasound Device

Co-founded in 2016 by Dave Hughes, Ph. D., and Richard Cooper, Novosound focuses on developing revolutionary imaging sensors to address the limitations of conventional ultrasound sensors.

With cardiovascular diseases (CVDs) affecting more than half a billion globally, according to a report released by the World Heart Association in 2023, effective blood pressure monitoring can help reduce mortality and improve care outcomes.

As such, innovative cardiac health monitoring technologies like this newly developed ultrasonic monitor can make a significant difference by allowing people to monitor blood pressure without needing a cuff.

According to Dave Hughes, CEO and Founder of Novosound, the development of the novel ultrasound device marks a turning point in addressing global health problems.